Showing 31-40 of 2779 results for "".
Adult-Onset Cerebellar Ataxias
https://practicalneurology.com/diseases-diagnoses/movement-disorders/adult-onset-cerebellar-ataxias/31221/Pravin Khemani, MD, Medical Director, Movement Disorders Program, Swedish Neuroscience Institute, provides a framework for evaluation of adult-onset cerebellar ataxias.ELEVATE (Qulipta for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments; NCT04740827)
https://practicalneurology.com/programs/practical-neurology/elevate-qulipta-for-prophylaxis-of-migraine-in-participants-who-failed-previous-oral-prophylactic-treatments-nct04740827/31255/Patricia Pozo-Rosich, MD, PhD, Headache Specialist from the Vall d’Hebron University Hospital in Barcelona, Spain, provides an overview of the ELEVATE clinical trial.A Mark of Success?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-mark-of-success/31075/Achim Schneeberger, MD, talks about the Phase II study that demonstrated clinical and biomarker effects consistent with disease modification in Alzheimer's. (headphones recommended)Advances in the Evaluation of TBI
https://practicalneurology.com/diseases-diagnoses/tbi/advances-in-the-evaluation-of-tbi/30093/Welcome to Neurology: Disease Deep Dive. In this episode, Dr. Beth McQuiston, MD, RD, Medical Director at Abbott Laboratories, and Dr. David Okonkwo, MD, PhD, Professor of Neurological Surgery, Clinical Director of the Brain Trauma Research Center, and Director of the Neurotrauma Program at UniversiEpilepsy and Cognition
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/epilepsy-and-cognition/31717/An Interview with Barbara C. Jobst, MDNovember/December 2015 Case Challenge: A 70-Year-Old Man with a Sudden Lisp
https://practicalneurology.com/diseases-diagnoses/neuromuscular/novemberdecember-2015-case-challenge-a-70-year-o/31086/By Mohanad Alzubaidi, MD and Aziz Shaibani, MD, FACP, FAAN, FANA A 70-year-old man presented with a six-month history of a "lisp," noted by his friends, that got worse the more he spoke. There was no diplopia, ptosis, dysphagia, muscle wasting, or extremities weakness. Since he was stresse- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31295/Management of Acute Seizures and Long-Term Antiepileptic Therapy: A Case StudyIn a recent article by Niranjan Siva, MD, and Amit Verma, MD, published in *Practical Neurology*, a 24-year-old male experienced two first-time generalized tonic-clonic seizures without aura within a two-hour period. Initi
RENEU (A Study to Evaluate the Safety, Effectiveness, and Tolerability of Gomekli in Children Aged ≥2 Years and Adults with an Inoperable NF1-PN; NCT03962543)
https://practicalneurology.com/programs/practical-neurology/trials-in-2/35433/Christopher Moertel, MD, Medical Director of the Pediatric Neuro-Oncology and Neurofibromatosis Programs at the University of Minnesota provides an overview of the ReNeu clinical trial which evaluated the safety, effectiveness, and tolerability of Gomekli in children aged ≥2 years and adults.The Role of Advanced Genomic Testing in the Diagnosis and Treatment of Neurologic Conditions
https://practicalneurology.com/programs/practical-neurology/the-role-of-advanced-genomic-testing-in-the-diagnosis-and-treatment-of-neurologic-conditions/30100/Paul Kruszka, MD, Chief Medical Officer at GeneDx, discusses advanced genomic testing, emphasizing how these tests are used to guide diagnosis and treatment decisions associated with neurodevelopmental conditions, including genetic variants associated with epilepsy.Physicians with Substance Use Disorder, Part II: Available Treatment and Recovery Options
https://practicalneurology.com/columns/practice-management/physicians-with-substance-use-disorder-part-ii-available-treatment-and-recovery-options/30091/Chris Bundy, MD, Executive Medical Director, Washington Physicians Health Program, provides an overview of treatment and recovery options available to physicians with substance use disorder, including peer-to-peer support, medication, and Physician Health Programs.